Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier in June revoking notices they ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

The heads of national HIV organizations have stepped up their advocacy, asking Congress to oppose cuts in President Donald ...

The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...

To compensate for tax cuts for the wealthy, Trump’s 'big, beautiful' bill and budget proposal for fiscal year 2026 threaten to curtail Medicaid, which provides health coverage for people with low ...

States and cities were prepared to submit the information they collected to the CDC in April so the agency's statisticians could prepare the volumes of data for analysis.

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...